AN EFFICACY AND SAFETY STUDY OF APALUTAMIDE (JNJ-56021927) IN COMBINATION WITH ABIRATERONE ACETATE AND PREDNISONE VERSUS ABIRATERONE ACETATE AND PREDNISONE IN PARTICIPANTS WITH CHEMOTHERAPY-NAIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC):